Status:
COMPLETED
ZTE MRI Pulse Sequence Use for Visualization of Bone Cement, Breast Biopsy Markers
Lead Sponsor:
Mayo Clinic
Collaborating Sponsors:
National Institute for Biomedical Imaging and Bioengineering (NIBIB)
Conditions:
Breast Carcinoma
Eligibility:
All Genders
18+ years
Brief Summary
This study is being done to determine if a clinically available MRI sequence called ZTE imaging better visualizes breast biopsy markers made of bone cement compared to the currently used breast biopsy...
Detailed Description
PRIMARY OBJECTIVE: I. To demonstrate that clinically available ZTE imaging allows for better visualization of bone cement breast biopsy markers when compared to conventional breast biopsy markers and...
Eligibility Criteria
Inclusion
- Age of 18 or older
Exclusion
- Cardiac pacemaker
- Implanted cardiac defibrillator
- Internal pacing wires
- Cerebral, carotid, or aortic aneurysmal clips
- Cochlear implants
- Implanted tissue expanders
- Claustrophobia
- Cannot lay prone
- Pregnant
Key Trial Info
Start Date :
April 11 2025
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 25 2025
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06873802
Start Date
April 11 2025
End Date
July 25 2025
Last Update
September 9 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905